Overview: Hepatitis C Antibody TestIntroduction: The Hepatitis C Antibody Test detects antibodies to hepatitis C virus (HCV) to diagnose infection, causing fatigue or jaundice. Following 2023 AASLD guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment decisions, and improving outcomes in serology for patients with suspected hepatitis C, which can lead to chronic liver disease if untreated.
Other Names: Anti-HCV Assay, Hepatitis C Serology Test.
FDA Status: FDA-cleared diagnostic test, meeting serology standards for diagnostic accuracy.
Historical Milestone: HCV antibody testing began in the 1990s after the virus's discovery. Immunoassays improved in the 2000s, enhancing diagnostic sensitivity.
Purpose: Diagnoses hepatitis C infection, guides treatment, and monitors anti-HCV antibodies in patients with fatigue, jaundice, or risk factors to prevent liver complications.
Test Parameters: 1. Hepatitis C Antibody
Pretest Condition: No fasting required. Collect serum or saliva at any time. Report symptoms like fatigue, jaundice, or nausea, and list medications or risk factors (e.g., IV drug use).
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, jaundice, nausea, or history of hepatitis C exposure. Include current medications, risk factors (e.g., blood transfusions), and vaccination status.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiviral therapy or follow-up testing.
Procedural Considerations: Uses an immunoassay to detect anti-HCV antibodies. Results are available in 1-2 days, enabling rapid clinical decisions. Performed in laboratories, often as a screening tool for high-risk populations.
Factors Affecting Result Accuracy: Improper sample handling or early infection can affect results. False positives may occur in low-risk populations, requiring confirmatory testing.
Clinical Significance: Positive anti-HCV indicates past or current hepatitis C infection, prompting HCV RNA testing for confirmation. Negative results may require repeat testing in early infection.
Specialist Consultation: Consult a hepatologist or infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: HCV RNA PCR, liver function tests, or HCV genotype testing to confirm infection and guide therapy.
Test Limitations: Cannot differentiate acute from chronic infection. False positives may occur in low-prevalence settings. Confirmatory testing is essential.
References: AASLD Hepatitis C Guidelines, 2023; Hepatology, Ghany MG, 2022.
